En Es
Categories

Alere

Alere

Develops rapid point-of-care diagnostics that focus on infectious disease, cardiology, oncology, drugs of abuse, and women's health.
Products NewsSummary
Close

News of Alere

Global Lateral Flow Assay Market to Exceed 8 Billion by 2022

08 Sep 2017
Global Lateral Flow Assay Market to Exceed 8 Billion by 2022
The global lateral flow assay market is projected to grow at a CAGR of 8.2% from USD 5.55 billion in 2017 to USD 8.24 billion by 2022, driven mainly by the high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care (POC) testing, and rising use of home-based lateral flow assay devices. These are the latest findings of Research and Markets, a global market research company.
Read More
Close

About Alere

Year of Establishment: 1981
Develops rapid point-of-care diagnostics that focus on infectious disease, cardiology, oncology, drugs of abuse, and women's health.

Recently updated

CD4 T-Cell Analyzer
Alere Pima

The Alere Pima enables CD4 T-cell analysis at the point-of-care from a fingerstick or venous whole-blood sample in only 20 minutes, providing an effective and affordable tool in the management of HIV patients. It is specifically designed to serve the needs of healthcare professionals in the field, laboratory or office and allows them to monitor the patients while they are still under their care.
More details

Cholesterol Analyzer
Alere Cholestech LDX

The Alere Cholestech LDX is a CLIA-waived point-of-care analyzer for lipid profile, cholesterol, and glucose testing with unique safeguards, automated checks and calibrations to ensure accurate results and eliminate user error. Its rapid results provide immediate awareness and identification of cardiovascular and diabetes health risks in only five minutes using fingerstick sampling and a small sample size (40μL).
More details

POC Molecular Analyzer
Alere q

The Alere q is a fully automated nucleic acid testing platform that enables point-of-care access to a suite of molecular assays, bypassing issues with centralized testing and reducing patient loss to follow up. It offers on the spot real-time polymerase chain reaction (PCR) with multiplexing capability and is easy to use without specialist laboratory skills for lab accurate results.
More details

Clinical Laboratory

CD4 T-Cell Analyzer
Alere Pima

The Alere Pima enables CD4 T-cell analysis at the point-of-care from a fingerstick or venous whole-blood sample in only 20 minutes, providing an effective and affordable tool in the management of HIV patients. It is specifically designed to serve the needs of healthcare professionals in the field, laboratory or office and allows them to monitor the patients while they are still under their care.
More details

Cholesterol Analyzer
Alere Cholestech LDX

The Alere Cholestech LDX is a CLIA-waived point-of-care analyzer for lipid profile, cholesterol, and glucose testing with unique safeguards, automated checks and calibrations to ensure accurate results and eliminate user error. Its rapid results provide immediate awareness and identification of cardiovascular and diabetes health risks in only five minutes using fingerstick sampling and a small sample size (40μL).
More details

POC Molecular Analyzer
Alere q

The Alere q is a fully automated nucleic acid testing platform that enables point-of-care access to a suite of molecular assays, bypassing issues with centralized testing and reducing patient loss to follow up. It offers on the spot real-time polymerase chain reaction (PCR) with multiplexing capability and is easy to use without specialist laboratory skills for lab accurate results.
More details

Multi-assay Analyzer
Alere Afinion 2

The Alere Afinion 2 is a compact, rapid, multi-assay analyzer designed for fast and easy to test quantitative determinations of HbA1c, Lipid Panel, ACR, and CRP near the patient at the point-of-care. It automatically transfers patient and control results to a HIS or LIS system, eliminating the need to send test results to the lab or spend time tracking them down.
More details

Immunoassay Analyzer
Alere Reader

The Alere Reader camera-based instrument detects the presence of and identifies a completed lateral flow assay, analyzes the intensity of the test and control line, and displays the results on the color touch screen. It features barcode technology to maximize data entry accuracy and minimize human error, while ensuring that quality controls are tested.
More details

Molecular Diagnostics System
i Strep A

The i Strep A is a molecular platform that detects Group A Streptococcus (GAS) bacteria in throat swab specimens and provides results in eight minutes or less on the Alere i platform. The CLIA-waived test is faster than other molecular methods and more accurate than conventional rapid tests, making it suitable for use in physician offices, hospital emergency rooms, and retail and walk-in clinics.
More details

Rapid Test System
Alere i

The Alere i is a rapid, instrument-based system featuring isothermal nucleic acid amplification technology for providing molecular results in minutes. It has a visual touchscreen along with a large screen for displaying results and is suitable for qualitative detection of infectious diseases.
More details

Analyzer
Afinion AS100 Analyzer

The Afinion AS100 and test cartridges have been precision engineered with each test cartridge containing an integrated sample collection device and all necessary reagents for a single test. It features integrated error detection and self-check systems, and enables on-the-spot testing, regardless of the sample type, whole blood, plasma or urine.
More details

Point of Care HIV Test
HIV Combo

The HIV Combo is a rapid POC test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, which can appear days after infection and prior to HIV-1/2 antibodies. The test detects all subtypes and recombinants of the virus more prevalent in Africa, Europe, Asia and Latin America.
More details

Influenza A&B Test
Alere i

The Alere i rapid molecular test is created to detect and differentiate influenza A and B virus in less than 15 minutes. The design of the test does not require temperature cycling like PCR testing, and therefore can deliver accurate results more quickly.
More details
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions